Compare BLCO & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | BIRK |
|---|---|---|
| Founded | 1853 | 1774 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2022 | 2023 |
| Metric | BLCO | BIRK |
|---|---|---|
| Price | $17.32 | $35.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | $18.45 | ★ $61.43 |
| AVG Volume (30 Days) | 389.8K | ★ 2.8M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.65 | $13.71 |
| Revenue Next Year | $5.59 | $14.30 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.77 | $31.33 |
| 52 Week High | $18.92 | $53.31 |
| Indicator | BLCO | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 60.73 | 38.12 |
| Support Level | $16.26 | $32.20 |
| Resistance Level | $17.36 | $42.18 |
| Average True Range (ATR) | 0.43 | 1.70 |
| MACD | 0.03 | -0.22 |
| Stochastic Oscillator | 70.37 | 7.68 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.